A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: Toxicity of a three- versus a four-week schedule
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Seminars in Oncology
- Vol. 28 (3H) , 10-14
- https://doi.org/10.1053/sonc.2001.23804
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: